Sylentis

Two biotechs target dry eye disease after Novartis’ Xiidra problems
Pharmaforum
Thu, 03/4/21 - 09:57 am
dry eye disease
Novartis
Xiidra
Sylentis
Azura Ophthalmics
Sylentis' dry eye drug misses primary goals in phase 3
Fierce Biotech
Thu, 01/31/19 - 11:55 pm
Sylentis
dry eye disease
PharmaMar
siRNA
tivanisiran
clinical trials